HERO

HERO (Hemophilia Experiences, Results and Opportunities) is an international, multidisciplinary initiative led by the HERO International Advisory Board and supported by Novo Nordisk.

At the heart of the HERO initiative is the HERO study, the largest ever, multinational, multi-method study of 1386 people in 11 countries.

HERO aims to improve outcomes in hemophilia by calling for and enabling enhanced psychosocial support based on increased understanding and awareness of the issues.


免费中文字幕午夜理论,亚洲一日韩欧美中文字幕在线,中文字幕乱视频在线观看